Unique Plan Description: Sepsis and Septic Shock
Plan Selection Display: Sepsis and Septic Shock
PlanType: Medical                                 
Version: 2          
Begin Effective Date: 2023-12-14 15:19:00
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2024-04-16 14:12:18
Available at all facilities: Yes

Sepsis and Septic Shock
Laboratory
	Lactate
		Stat, spec type = Blood
	Blood Gases Arterial (ABG) - MH/WH/JE
		T;N, Stat, spec type = Blood
	Blood Gases Arterial (ABG) - FH
		T;N, Stat, spec type = Blood
	Procalcitonin
		Stat, spec type = Blood
	hsCRP
		Stat, spec type = Blood
	CBC with Diff
		Stat, spec type = Blood
	Comprehensive Metabolic Panel
		Stat, spec type = Blood
	Hepatic Function Panel
		Stat, spec type = Blood
	Basic Metabolic Panel
		Stat, spec type = Blood
	INR - MH/WH/JE
		Stat, spec type = Blood
	Prothrombin Time (PT) - FH
		T;N, Stat, spec type = Therapeutic Blood
	Partial Thromboplastin Time (PTT) - FH
		T;N, Stat, spec type = Diagnostic Blood
	PTT - MH/WH/JE
		T;N, Stat, spec type = Blood
	Sputum Culture
		Routine, Expectorated, spec type = Sputum, Sputum
	D-Dimer - MH/WH/JE
		Stat, spec type = Blood
	D-Dimer Level - FH
		T;N, Stat, spec type = Blood
	Fibrinogen Level - MH/WH/JE
		T;N, Stat, spec type = Blood
	Fibrinogen Level - FH
		T;N, Stat, spec type = Blood
	Culture Wound
		T;N, Routine
	UA (Culture if Positive)
		T;N, Routine, Routine, UA Cult Clean Catch, Midvoid, spec type = Urine
Diagnostic Tests
	Chest 1 View
		Stat
IV Solutions
	Lactated Ringers - Sepsis
		30 mL/kg, IVPB, Once, STAT
			Comment: Infuse at 999ml/hr or within 3 hours, whichever is faster.
	Sodium Chloride 0.9% - Sepsis
		30 mL/kg, IVPB, Once, STAT
			Comment: Infuse at 999ml/hr or within 3 hours, whichever is faster.
	Sodium Chloride 0.9% Intravenous Solution (Bolus)
		250 mL, IV, 1 hr, Fluid challenge bolus
		500 mL, IV, 1 hr, Fluid challenge bolus
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
	norepinephrine 4mg/D5W 250mL Premix
		250 mL, IV, STAT, Duration: 1 Dose(s)/Time(s), Increment Increase: 1 mcg/min, Increment Decrease: 1 mcg/min, Increment Freq: 3 min(s), Max Dose: 30 mcg/min
			Comment: **LEVOPHED** Concentration: 16mcg/mL .  If the dose has been titrated twice within the specified timeframe and goal parameter is not achieved, the titration dose can be doubled until the ordered parameter is achieved or maximum dose is reached.  IV may be re-initiated after weaning within 12hours, re-initiate at the last dosing rate that maintained Goal parameter. Discontinue order after 12hr if patient does not require IV re-initiation.
		4 mg, EVERY BAG, 8 mcg/min
	norepinephrine 8mg/D5W 250mL Premix
		250 mL, IV, STAT, Duration: 1 Dose(s)/Time(s), Increment Increase: 1 mcg/min, Increment Decrease: 1 mcg/min, Increment Freq: 3 min(s), Max Dose: 30 mcg/min
			Comment: **LEVOPHED** Concentration: 32mcg/mL .  If the dose has been titrated twice within the specified timeframe and goal parameter is not achieved, the titration dose can be doubled until the ordered parameter is achieved or maximum dose is reached.  IV may be re-initiated after weaning within 12hours, re-initiate at the last dosing rate that maintained Goal parameter. Discontinue order after 12hr if patient does not require IV re-initiation.
		8 mg, EVERY BAG, 8 mcg/min
	EPINEPHrine 5 mg/NS 250 mL
		250 mL, IV, STAT, Increment Increase: 10 mcg/min, Increment Decrease: 10 mcg/min, Increment Freq: 3 min(s), Max Dose: 180 mcg/min
			Comment: Concentration: 20mcg/mL.  If the dose has been titrated twice within the specified timeframe and goal parameter is not achieved, the titration dose can be doubled until the ordered parameter is achieved or maximum dose is reached.  IV may be re-initiated after weaning within 12hours, re-initiate at the last dosing rate that maintained Goal parameter. Discontinue order after 12hr if patient does not require IV re-initiation.
		5 mg, EVERY BAG, 1 mcg/min
	vasopressin 10units/NS 50mL
		50 mL, IV, STAT, Increment Increase: 0.01 unit/min, Increment Decrease: 0.01 unit/min, Increment Freq: 30 min(s), Max Dose: 0.1 unit/min
			Comment:  If the dose has been titrated twice within the specified timeframe and goal parameter is not achieved, the titration dose can be doubled until the ordered parameter is achieved or maximum dose is reached.  IV may be re-initiated after weaning within 12hours, re-initiate at the last dosing rate that maintained Goal parameter. Discontinue order after 12hr if patient does not require IV re-initiation.
		10 units, EVERY BAG, 0.01 unit/min
	phenylephrine 20 mg/NS 250 mL
		250 mL, IV, STAT, Increment Increase: 10 mcg/min, Increment Decrease: 10 mcg/min, Increment Freq: 3 min(s), Max Dose: 180 mcg/min
			Comment: **NEO-SYNEPHRINE** Concentration: 80mcg/mL.  If the dose has been titrated twice within the specified timeframe and goal parameter is not achieved, the titration dose can be doubled until the ordered parameter is achieved or maximum dose is reached.  IV may be re-initiated after weaning within 12hours, re-initiate at the last dosing rate that maintained Goal parameter. Discontinue order after 12hr if patient does not require IV re-initiation.
		20 mg, EVERY BAG, 100 mcg/min
Medications
Consults/Follow-up
	Consult Infectious Disease
		Sepsis
	Consult Pulmonologist
		Reason for Referral: Sepsis
	Pharmacy Consult
		Review meds and dose adjust in accordance with renal/hepatic function.

Blood Culture Set
Laboratory
	.Blood Culture.
		T;N, Stat, spec type = Blood
		T;N, Routine, spec type = Blood
		Timed, spec type = Blood
		T+1;0400, Routine, spec type = Blood
	.Blood Culture
		T;N, Stat, spec type = Blood
		T;N, Routine, spec type = Blood
		Timed, spec type = Blood
		T+1;0400, Routine, spec type = Blood

(Subphase)Bone Infection/Osteomyelitis
Medications
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Bone/joint/osteo, STAT
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Zosyn IVPB
		4.5 gm, Injection-Premix, IVPB, Q8H, Indication: Bone/joint/osteo
	Zosyn IVPB (FH)
		4.5 gm, INT, IVPB, Q8H, Indication: Bone/joint/osteo
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Bone/joint/osteo
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Bone/joint/osteo
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	cefepime IVPB
		2,000 mg, Injection-Premix, IVPB, Q8H, Indication: Bone/joint/osteo
	cefepime IVPB (FH)
		2,000 mg, INT, IVPB, Q8H, Indication: Bone/joint/osteo

(Subphase)Febrile Neutropenia
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20874(NOTE)*
	cefepime (FH/WH)
		2,000 mg, INT, IVPB, Q8H, Indication: Other- type in, febrile-neutropenia
	cefepime IVPB
		2,000 mg, Injection-Premix, IVPB, Q8H, Indication: Other- type in, febrile-neutropenia
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20874(NOTE)*
	Levaquin IVPB
		750 mg, Injection-Premix, IVPB, Q24H, Indication: Febrile neutropenia

(Subphase)Intra-Abdominal Source
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(255,255,255);margin:0; P margin:0 </STYLE><META name=GENERAT(NOTE)*
		750 mg, Injection-Premix, IVPB, Q24H, Indication: Intra-abdominal
	Flagyl IVPB
		500 mg, Injection-Premix, IVPB, Q8H, Indication: Intra-abdominal
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(255,255,255);margin:0; P margin:0 </STYLE><META name=GENERAT(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Intra-abdominal
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Intra-abdominal
	Flagyl IVPB
		500 mg, Injection-Premix, IVPB, Q8H, Indication: Intra-abdominal
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(255,255,255);margin:0; P margin:0 </STYLE><META name=GENERAT(NOTE)*
	Zosyn IVPB
		4.5 gm, Injection-Premix, IVPB, Q8H, Indication: Intra-abdominal
	Zosyn IVPB (FH)
		4.5 gm, INT, IVPB, Q8H, Indication: Intra-abdominal
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(255,255,255);margin:0; P margin:0 </STYLE><META name=GENERAT(NOTE)*
	vancomycin oral
		125 mg, Capsule, By Mouth, QID, Indication: C difficile
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(255,255,255);margin:0; P margin:0 </STYLE><META name=GENERAT(NOTE)*
	Flagyl IVPB
		500 mg, Injection-Premix, IVPB, Q8H, Indication: C difficile

(Subphase)Meningitis
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, CNS-meningitis, STAT
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q12H, Indication: CNS-meningitis
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q12H, Indication: CNS-meningitis
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, CNS-meningitis, STAT
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q12H, Indication: CNS-meningitis
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q12H, Indication: CNS-meningitis
	ampicillin IVPB
		2,000 mg, INT, IVPB, Q4H, Indication: CNS-meningitis
	ampicillin IVPB (FH)
		2,000 mg, INT, IVPB, Q4H, Indication: CNS-meningitis

(Subphase)OB Infection
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	ampicillin IVPB
		2,000 mg, INT, IVPB, Q6H, Indication: Other- type in, Chorioamnionitis
	ampicillin IVPB (FH)
		2,000 mg, INT, IVPB, Q6H, Indication: Other- type in, Chorioamnionitis
	gentamicin IVPB
		5 mg/kg, INT, IVPB, Q24H, Indication: Other- type in, Chorioamnionitis
	gentamicin IVPB (FH)
		5 mg/kg, INT, IVPB, Q24H, Indication: Other- type in, Chorioamnionitis
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Ancef IVPB
		1,000 mg, Injection-Premix, IVPB, Q8H, Indication: Other- type in, Chorioamnionitis
	Ancef IVPB (FH)
		1,000 mg, INT, IVPB, Q8H, Indication: Other- type in, Chorioamnionitis
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	ampicillin IVPB
		2,000 mg, INT, IVPB, Q6H, Indication: Other- type in, Chorioamnionitis
	ampicillin IVPB (FH)
		2,000 mg, INT, IVPB, Q6H, Indication: Other- type in, Chorioamnionitis
	gentamicin IVPB
		5 mg/kg, INT, IVPB, Q24H, Indication: Other- type in, Chorioamnionitis
	gentamicin IVPB (FH)
		5 mg/kg, INT, IVPB, Q24H, Indication: Other- type in, Chorioamnionitis
	Flagyl IVPB
		500 mg, Injection-Premix, IVPB, Q8H, Indication: Other- type in, Chorioamnionitis
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Other- type in, Chorioamnionitis, STAT
	gentamicin IVPB
		5 mg/kg, INT, IVPB, Q24H, Indication: Other- type in, Chorioamnionitis
	gentamicin IVPB (FH)
		5 mg/kg, INT, IVPB, Q24H, Indication: Other- type in, Chorioamnionitis
	Flagyl IVPB
		500 mg, Injection-Premix, IVPB, Q8H, Indication: Other- type in, Chorioamnionitis
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	clindamycin IVPB
		900 mg, Injection-Premix, IVPB, Q8H, Indication: Gyn infection
	gentamicin IVPB
		5 mg/kg, INT, IVPB, Q24H, Indication: Gyn infection
	gentamicin IVPB (FH)
		5 mg/kg, INT, IVPB, Q24H, Indication: Gyn infection
	Flagyl IVPB
		500 mg, Injection-Premix, IVPB, Q8H, Indication: Gyn infection
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Mefoxin IVPB
		2,000 mg, INT, IVPB, Q6H, Indication: Other- type in, Gyn infection
	doxycycline IVPB
		100 mg, INT, IVPB, Q12H, Indication: Gyn infection

(Subphase)Pneumonia
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Pneumonia-Community acquired
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Pneumonia-Community acquired
	Zithromax IVPB
		500 mg, INT, IVPB, Q24H, Indication: Pneumonia-Community acquired
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Levaquin IVPB
		750 mg, Injection-Premix, IVPB, Q24H, Indication: Pneumonia-Community acquired
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Zosyn IVPB
		4.5 gm, Injection-Premix, IVPB, Q8H, Indication: Pneumonia-Community acquired
	Zosyn IVPB (FH)
		4.5 gm, INT, IVPB, Q8H, Indication: Pneumonia-Community acquired
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Pneumonia-Community acquired, STAT
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	cefepime IVPB
		2,000 mg, Injection-Premix, IVPB, Q8H, Indication: Pneumonia-Community acquired
	cefepime IVPB (FH)
		2,000 mg, INT, IVPB, Q8H, Indication: Pneumonia-Community acquired
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Pneumonia-Community acquired, STAT
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Levaquin IVPB
		750 mg, Injection-Premix, IVPB, Q24H, Indication: Pneumonia-Community acquired
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Pneumonia-Community acquired, STAT
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Levaquin IVPB
		750 mg, Injection-Premix, IVPB, Q24H, Indication: Pneumonia-Community acquired
	Zosyn IVPB
		4.5 gm, Injection-Premix, IVPB, Q8H, Indication: Pneumonia-Community acquired
	Zosyn IVPB (FH)
		4.5 gm, INT, IVPB, Q8H, Indication: Pneumonia-Community acquired
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Levaquin IVPB
		750 mg, Injection-Premix, IVPB, Q24H, Indication: Pneumonia-Community acquired
	cefepime IVPB
		2,000 mg, Injection-Premix, IVPB, Q8H, Indication: Pneumonia-Community acquired
	cefepime IVPB (FH)
		2,000 mg, INT, IVPB, Q8H, Indication: Pneumonia-Community acquired

(Subphase)Source Not Clear (Not Neutropenic)
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Bacteremia, STAT
	Zosyn IVPB
		4.5 gm, Injection-Premix, IVPB, Q8H, Indication: Bacteremia
	Zosyn IVPB (FH)
		4.5 gm, INT, IVPB, Q8H, Indication: Bacteremia
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Bacteremia, STAT
	cefepime IVPB
		2,000 mg, Injection-Premix, IVPB, Q12H, Indication: Bacteremia
	cefepime IVPB (FH)
		2,000 mg, INT, IVPB, Q8H, Indication: Bacteremia

(Subphase)Urinary Source
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: UTI
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: UTI
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	cefepime IVPB
		2,000 mg, Injection-Premix, IVPB, Q12H, Indication: UTI
	cefepime IVPB (FH)
		2,000 mg, INT, IVPB, Q8H, Indication: UTI
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Zosyn IVPB
		4.5 gm, Injection-Premix, IVPB, Q8H, Indication: UTI
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: UTI
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: UTI

(Subphase)Wound Infection
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Skin soft tissue, STAT
	Zosyn IVPB
		4.5 gm, Injection-Premix, IVPB, Q8H, Indication: Skin soft tissue
	Zosyn IVPB (FH)
		4.5 gm, INT, IVPB, Q8H, Indication: Skin soft tissue
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Levaquin IVPB
		750 mg, Injection-Premix, IVPB, Q24H, Indication: Skin soft tissue
	Flagyl IVPB
		500 mg, Injection-Premix, IVPB, Q8H, Indication: Skin soft tissue
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Skin soft tissue, STAT
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Skin soft tissue
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Skin soft tissue
	Flagyl IVPB
		500 mg, Injection-Premix, IVPB, Q8H, Indication: Skin soft tissue
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Zosyn IVPB
		4.5 gm, Injection-Premix, IVPB, Q8H, Indication: Skin soft tissue
	Zosyn IVPB (FH)
		4.5 mg, INT, IVPB, Q8H, Indication: Skin soft tissue
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Skin soft tissue
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Skin soft tissue
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Skin soft tissue, STAT
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Skin soft tissue
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Skin soft tissue

(Subphase)Intravascular Catheter Infection
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Bacteremia, STAT
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Bacteremia
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Bacteremia

(Subphase)Biliary Source
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Zosyn IVPB
		4.5 gm, Injection-Premix, IVPB, Q8H, Indication: Intra-abdominal
	Zosyn IVPB (FH)
		4.5 gm, INT, IVPB, Q8H, Indication: Intra-abdominal
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Levaquin IVPB
		750 mg, Injection-Premix, IVPB, Q24H, Indication: Intra-abdominal
	Flagyl IVPB
		500 mg, Injection-Premix, IVPB, Q8H, Indication: Intra-abdominal

(Subphase)Endocarditis
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Heart-endocarditis
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Heart-endocarditis
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Heart-endocarditis, STAT

(Subphase)Joint Infection/Septic Arthritis
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Bone/joint/osteo
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Bone/joint/osteo
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Bone/joint/osteo, STAT
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Bone/joint/osteo
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Bone/joint/osteo

(Subphase)Skin/Soft Tissue Infection
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Skin soft tissue
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Skin soft tissue
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Skin soft tissue, STAT
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Skin soft tissue
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Skin soft tissue
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY background-color: rgb(0,255,255);margin:0; P margin:0 </STYLE><META name=GENERATOR(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Rocephin IVPB
		2,000 mg, Injection-Premix, IVPB, Q24H, Indication: Skin soft tissue
	Rocephin IVPB (FH)
		2,000 mg, INT, IVPB, Q24H, Indication: Skin soft tissue
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Skin soft tissue, STAT
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20967(NOTE)*
	Zosyn IVPB
		4.5 gm, Injection-Premix, IVPB, Q8H, Indication: Skin soft tissue
	Zosyn IVPB (FH)
		4.5 gm, INT, IVPB, Q8H, Indication: Skin soft tissue
	vancomycin - Pharmacy to Dose
		Pharmacy to Dose, IVPB, PHARMACY TO DETERMINE, Skin soft tissue, STAT

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase